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ABSTRACT Pulmonary rehabilitation is considered a key management strategy for chronic obstructive
pulmonary disease (COPD), but its effectiveness is undermined by poor patient uptake and completion.
The aim of this review was to identify, select and synthesise the available evidence on interventions for
improving uptake and completion of pulmonary rehabilitation in COPD.
Electronic databases and trial registers were searched for randomised trials evaluating the effect of an
intervention compared with a concurrent control group on patient uptake and completion. The primary
outcomes were the number of participants who attended a baseline assessment and at least one session of
pulmonary rehabilitation (uptake), and the number of participants who received a discharge assessment
(completion).
Only one quasi-randomised study (n=115) (of 2468 records identified) met the review inclusion criteria
and was assessed as having a high risk of bias. The point estimate of effect did, however, indicate greater
programme completion and attendance rates in participants allocated to pulmonary rehabilitation plus a
tablet computer (enabled with support for exercise training) compared with controls (pulmonary
rehabilitation only).
There is insufficient evidence to guide clinical practice on interventions for improving patient uptake
and completion of pulmonary rehabilitation in COPD. Despite increasing awareness of patient barriers to
pulmonary rehabilitation, our review highlights the existing under-appreciation of interventional trials in
this area. This knowledge gap should be viewed as an area of research priority due to its likely impact in
undermining wider implementation of pulmonary rehabilitation and restricting patient access to a
treatment considered the cornerstone of COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterised by persistent and progressive airflow
limitation, with acute exacerbations of symptoms (dyspnoea, cough and sputum production) and
comorbidities contributing to the overall severity of the disease [1]. Globally, COPD is now the third
leading cause of mortality [2] and the second leading cause of disability-adjusted life-years lost [3]. In the
UK, mortality from COPD is almost double the European Union average, and has a high social and
economic burden as a leading cause of emergency admissions to hospital [4].
Pulmonary rehabilitation is defined as a “comprehensive intervention based on a thorough patient
assessment followed by patient-tailored therapies, which include, but are not limited to, exercise training,
education and behavior change, designed to improve the physical and psychological condition of people
with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors”
[5]. Pulmonary rehabilitation triggers moderate-to-large and clinically significant effects on maximal and
functional exercise capacity, dyspnoea and fatigue, emotional function, and sense of control that COPD
patients have over their condition [6]. Our confidence in the estimate of these effects is unlikely to change
with any further randomised controlled trials comparing pulmonary rehabilitation and conventional care
in COPD [7]. Furthermore, pulmonary rehabilitation delivered in the acute setting (post-exacerbation of
COPD) also reduces the risk of hospital readmissions and mortality [8]. Hence, national guidelines
recommend all patients with stable COPD and exercise limitation, due to breathlessness, should be
referred to pulmonary rehabilitation or should start a pulmonary rehabilitation programme within 4 weeks
of discharge from a hospital admission due to an acute exacerbation of COPD [9].
Although the beneficial effects of pulmonary rehabilitation are well established, patient uptake and completion
of the treatment remains poor. A recent clinical audit of pulmonary rehabilitation services in the UK reported
that only 42% of patients referred to pulmonary rehabilitation managed to complete the programmes [10].
Similar findings of poor patient engagement have also been reported across the pulmonary rehabilitation
service pathway in quantitative and qualitative studies worldwide [11]. Recent observational evidence suggests
that pulmonary rehabilitation in the acute setting presents the greatest challenge of patient acceptance, with
completion rates <15% [12, 13]. Major barriers to uptake and/or completion of pulmonary rehabilitation in a
stable or acute setting include travel and transport, perception of illness, lack of perceived benefit from
attendance, disruption to routine, inconvenient timing, influence of general practitioner, illness and
comorbidities, current smoking, depression, and lack of social support [11–17].
At a national and international level, it is widely accepted that healthcare providers urgently need to
respond to the challenges of patient uptake and completion of pulmonary rehabilitation by improving the
access to and the quality of services [18, 19]. While some barriers limiting patient acceptance of
pulmonary rehabilitation programmes may be overcome by improvement in access and quality of service
provision, there is an onus on the wider respiratory research community to identify the potential
interventions that can further advance evidence-based policy in pulmonary rehabilitation [18]. There is no
systematic review of interventions for improving uptake and/or completion of pulmonary rehabilitation.
There is a need for a robust synthesis of current evidence that will have maximum potential to inform
clinical practice and the design of future trials that assess the efficacy of interventions in improving uptake
and/or completion of pulmonary rehabilitation. Such a review is important to identify effective approaches
for supporting patient engagement with a treatment recognised to be one of the most cost-effective
treatments for COPD. The primary aim of this study was to systematically review the effects of
interventions for improving patient uptake and completion of pulmonary rehabilitation.
Methods
Methods of analysis and inclusion criteria were specified in advance and documented in a protocol that
was registered on PROSPERO (International Prospective Register of Systematic Reviews; www.crd.york.ac.
uk/PROSPERO/) with identifier CRD42016038524.
Selection criteria
Studies were considered for inclusion in this systematic review according to the following criteria.
Participants
Adults with a diagnosis of COPD confirmed by spirometry (in line with national or international criteria,
e.g. British Thoracic Society (BTS), American Thoracic Society (ATS)/European Respiratory Society (ERS) or
Global Initiative for Chronic Obstructive Lung Disease (GOLD)) and referred to pulmonary rehabilitation.
Where the aim of a study was to increase completion rate, participants are those referred and already enrolled
on to pulmonary rehabilitation at start of study.
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Intervention
Any intervention with the specific aim to improve patient uptake and/or completion of pulmonary
rehabilitation. Studies which aimed to improve patient uptake and/or completion of pulmonary rehabilitation
via interventions targeted at partners, carers, family members or healthcare providers/health professionals who
refer patients to/deliver pulmonary rehabilitation would also be included.
Comparison
Any concurrent control group referred to and/or enrolled on to pulmonary rehabilitation, but not
receiving an intervention aimed to improve patient uptake and/or completion (i.e. not beyond usual care).
Outcomes
Uptake of pulmonary rehabilitation (received baseline assessment and/or enrolled on to pulmonary
rehabilitation). Completion of pulmonary rehabilitation (received discharge assessment; total number of
sessions attended).
Study design
Randomised controlled trials that involved allocation of participants at an individual or cluster level, or via
a quasi-randomised method.
Search strategy
To identify any existing relevant systematic reviews we searched the Cochrane Database of Systematic
Reviews, PROSPERO, and the Database of Abstracts of Reviews of Effects of the National Institute of
Health Research (NIHR) Service Centre for Reviews and Dissemination. To identify primary studies, we
searched the following bibliographic databases: MEDLINE, Embase, CINAHL (Cumulative Index to
Nursing and Allied Health Literature), CENTRAL (Cochrane Central Register of Controlled Trials) and
PEDro (Physiotherapy Evidence Database). We searched the trial registers ClinicalTrials.gov, Current
Controlled trials, and Health Technology Assessment in progress of the NIHR Service Centre for Reviews
and Dissemination. We also searched EThOS (British Library) and Conference Proceedings Citation Index
(Web of Science Core Collection). All information sources were searched between March 24, 2016 and
April 28, 2016. No limits on publication date or language were set. Key search terms were structured
around the population (e.g. “Lung Diseases, Obstructive”, “COPD”), intervention target (e.g. “exercise
therapy”, “rehabilitat*”), outcomes (e.g. “adherence”, “attendance”) and study type (e.g. “randomised” or
“randomized”, “random allocation”). A full electronic search strategy for one database is provided in the
supplementary material. Database searching was supplemented by contact with study authors, experts and
research groups, forward and backward citation tracking from included studies or review articles, and
continued monitoring with internet searches (e.g. Google Scholar) until June 14, 2016.
Search results were compiled using EndNote (Clarivate Analytics, Philadelphia, PA, USA). Duplicate
citations were removed, and titles and abstracts screened independently by two reviewers against the
inclusion criteria. Full-text articles were retrieved and assessed by two reviewers when studies were not
excluded based on title or abstract. Discrepancies were resolved through discussion and inclusion of a third
reviewer.
Data extraction and quality appraisal
We developed, tested and refined a structured data collection form based on the Cochrane data extraction
template for interventions. One reviewer extracted data, which was cross-checked for accuracy by a second
reviewer. The following information was extracted: methods of study (date/title of study, aim of study,
study design, unit of allocation, duration of study, duration of intervention, primary outcome, other
outcomes, funding source), participants (age, sex, disease severity, comorbidities, inclusion criteria,
exclusion criteria, method of recruitment of participants, total number randomised, clusters, baseline
imbalances), intervention/comparator (group names, number randomised to group-sample size, delivery,
content, timing, frequency, duration, providers, co-interventions) and outcomes (name/definition, type,
unit of analysis, person measuring/reporting, missing participants/data, reasons missing).
Two reviewers independently assessed the risk of bias for any studies included in the review using the
Cochrane Risk of Bias Table with the following domains: random sequence generation, allocation
concealment, blinding (outcome assessors) incomplete outcome data, selective outcome reporting and
other bias [20]. Each domain was classified as adequate, unclear or inadequate, with the overall risk of bias
for the study classified using the following criteria: 1) low risk of bias (all criteria deemed adequate), 2)
moderate risk of bias (one criterion graded inadequate or two graded unclear) and 3) high risk of bias
(more than one criterion deemed inadequate or more than two graded unclear). A third reviewer was
available to resolve any disagreements between the two reviewers. Due to the nature of the interventions,
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blinding of participants and personnel to treatment allocation was not expected, and hence blinding only
applied to outcome assessors.
Data analysis
The primary measure of effect for uptake of pulmonary rehabilitation was defined as total number of
participants in each group who received baseline assessment and attended at least one session of
pulmonary rehabilitation. Total number of participants who received a baseline assessment but did not
enrol on to pulmonary rehabilitation was a secondary summary measure. The primary measure for
completion of pulmonary rehabilitation was defined as total number of participants who received a
discharge (follow-up) assessment. All of these were treated as dichotomous outcomes and were interpreted
as risk ratios. We also included the number of sessions of pulmonary rehabilitation attended by
participants as a secondary summary measure. This was treated as count data and interpreted as rate ratios
(total number of sessions attended by participant/total number of sessions prescribed to participant).
If there were a sufficient number of studies that overlapped in terms of outcome measures, we planned to
pool these data together (with participant as the unit of analysis) in a meta-analysis using a generic inverse
variance random effects method and explore any sources (e.g. clinical and/or methodological diversity) of
heterogeneity identified by the I2-test statistic. Due to the insufficient amount of evidence, we provide a
narrative synthesis of our findings.
Our pre-specified sensitivity analyses included assessing the effect of removing included studies classified
as medium or high risk of bias within the Cochrane Risk of Bias Table. We planned to carry out subgroup
analysis on the primary measures of effect using the following: setting of pulmonary rehabilitation
(hospital, community or home), severity of COPD (GOLD stages), timing of pulmonary rehabilitation (<4
or >4 weeks post-exacerbation), source of pulmonary rehabilitation referral (referrer and contact method)
and study design (individually randomised versus cluster). However, there were too few studies to conduct
the above analyses.
Results
After removal of duplicates, searching identified 2468 distinct citations. 2429 citations were excluded during
the initial screening phase (titles and abstracts) (figure 1). For the remaining 39 citations, full-text papers
Records identified through 
search strategy
(n=2914)
Records screened 
(n=2468)
Full-text articles assessed 
for eligibility
(n=39)
Included studies
(n=1)
Records identified through other sources (n=2):
  Identified through references of systematic review (n=1)
  Handsearching (n=1)
Duplicate citations removed (n=448)
Records excluded based on titles (n=1382) and abstracts (n=1047)
Excluded studies (n=38):#
  Compared different pulmonary rehabilitation programmes (n=1)
  Not a randomised trial (n=2)
  Not enrolled on pulmonary rehabilitation (n=7)
  Did not report uptake or completion outcomes (n=33)
FIGURE 1 Flow diagram of study selection. #: some studies excluded for multiple reasons.
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TABLE 1 Characteristics of included studies
Study (country) Study design Participants Intervention Comparison Outcomes
RINGBAEK et al. [21]
(Denmark)
Quasi-randomised
trial (allocation by
alternation)
Intervention: 46 participants,
age 68±9 years, 55%
male, BMI 24±5 kg·m−2,
FEV1 31±9% predicted,
current smokers 14%,
long-term oxygen therapy 7%,
CAT score 20±7,
MRC dyspnoea
score 4 (2–5).
Control: 69 participants, age
69±11 years, 39% male, BMI
25±6 kg·m−2, FEV1 35±11%
predicted, current smokers
17%, long-term oxygen
therapy 13%, CAT score 19±6,
MRC dyspnoea
score 4 (2–5).
Use of a wireless tablet computer
(Nexus 7) with mobile-based
internet connectivity plus usual
care. The tablet software
consisted of 1) a training diary
(including the type, frequency,
duration of exercises, and
registered dyspnoea after each
exercise using the Borg
dyspnoea score),
2) video recordings of all the
training exercises used and 3)
training results for patients to
monitor their own training. Staff
had access to this information,
and used it discuss progress,
individual barriers and
opportunities as well as to
encourage further training.
Usual care: pulmonary
rehabilitation twice weekly for
7 weeks at one of two hospitals
(Gentofte Hospital and Hvidovre
Hospital) or 10 weeks at
Nordsjælland Hospital with
each session lasting 2 h. Each
session consisted of 1 h of
supervised exercise and 1 h of
education. The supervised
training sessions consisted of
walking and cycling. Patients
were instructed to exercise at a
level equal to 85% of predicted
peak oxygen uptake as
calculated from the
incremental shuttle walk test.
Dropout rates.
1) Completion of rehabilitation:
intervention 42 out of 46
participants; control 57 out of 69
participants. 2) Sessions
attended: intervention 631 out of
784 sessions; control 509 out of
724 sessions.
Data are presented as mean±SD or mean (range), unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in 1 s; CAT: COPD Assessment Test; MRC: Medical
Research Council.
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were obtained and subsequently assessed independently against the eligibility criteria by two reviewers with
discrepancies resolved by discussion with a third reviewer. One study (2.5%) met the inclusion criteria [21]
and had extractable data on an intervention promoting completion of pulmonary rehabilitation (table 1).
The most common reason for exclusion of full-text papers was no measure of uptake or completion of
pulmonary rehabilitation. A full list of excluded studies, together with reasons for exclusion, can be found in
the supplementary material.
The one study included was published in 2016 [21]. The trial was conducted within secondary care
(pulmonary clinics) in Denmark and included 115 participants (42% males). The inclusion criteria for
entry into were a diagnosis of stable COPD (confirmed spirometry as forced expiratory volume in 1 s
(FEV1) <80% predicted and FEV1/forced vital capacity <70% predicted) and enrolment on to a pulmonary
rehabilitation programme at one of three hospitals. Exclusion criteria for the study were any
musculoskeletal, cardiac and cognitive disorders that limited the ability of the participants to train and
attend classes. A total of 146 participants were originally referred to pulmonary rehabilitation during the
study period, but 14 were excluded (no COPD diagnosis) and 17 refused to participate in the study.
This trial compared pulmonary rehabilitation plus use of a tablet computer with instructions and a
training diary (intervention group) to a pulmonary rehabilitation only group. Every second training group
was allocated to use a 7-inch tablet computer (Nexus 7; Asus, Taipei, Taiwan) and thus met our criteria of
study type of a quasi-randomised trial (i.e. alternation). The trial design did not involve any blinding. The
intervention lasted for the duration of pulmonary rehabilitation. Both groups included provision of
pulmonary rehabilitation for 7–10 weeks. The investigators hypothesised that, by providing a common
platform for cooperation between the patient and the health professionals, the intervention could empower
the patient to become an active participant evaluating his/her own improvements.
The intervention and the control group did not achieve comparable changes in the primary outcome
measures (endurance shuttle walk test (ESWT) and COPD Assessment Test (CAT)) following pulmonary
rehabilitation. The mean change in walking time (ESWT) was significantly better in the control group
compared with the intervention group, with this difference also being greater than the proposed minimal
clinical important difference (45–85 s) [22]. Although it was reported that the change in CAT score after
pulmonary rehabilitation did not differ significantly between groups, the intervention group demonstrated
a reduction that is considered to be clinically important (2 units) [23], while there was a modest increase
in CAT score in the control group.
Dropout rates (completion of pulmonary rehabilitation) were not specified as a primary outcome, but
rather labelled as a secondary effect parameter. Completion was defined as attending the evaluation visit
(assessment at end of pulmonary rehabilitation). Completion of pulmonary rehabilitation was treated as
discrete data and interpreted as a difference in group proportions. On request, authors of the study were
able to provide data on the number of sessions of pulmonary rehabilitation attended within study groups.
The point estimate of effect for the included trial indicated greater completion of pulmonary rehabilitation
among participants allocated to the intervention group compared with those allocated to the usual care
control group (risk ratio 1.11, 95% CI 0.96–1.28) (table 1). The difference in completion rates between
groups did not achieve statistical significance in the study. The rate of attendance at prescribed sessions
was greater in the intervention compared with the control group (rate ratio 1.15, 95% CI 1.14–1.16) (table
1). The included study was, however, considered to have a high overall risk of bias (table 2). Four (67%) of
the individual risk of bias domains were graded inadequate. This was mostly due to the nonblinded,
quasi-randomised allocation nature of the study.
We identified three study protocols describing at least three randomised trials (based in the UK) that meet
our eligibility criteria [24–26]. One of these is assessing the feasibility of a definitive randomised controlled
trial that will assess whether in-hospital exercise and in-home rehabilitation delivered in isolation or
concurrently following an acute exacerbation of COPD are clinically and cost-effective, including their
impact on subsequent attendance at community group-based pulmonary rehabilitation [24]. Another trial
is evaluating uptake to initial assessment of post-exacerbation pulmonary rehabilitation (primary outcome
measure) in response to a brief patient-designed educational video provided before invitation to the
programme [25]. The other protocol details a seamless three-phase study (phase I: preparation; phase II:
randomised pilot; phase III: a fully powered multicentre, individually randomised controlled trial) [26].
The aim is to determine the effect of a psychological intervention combined with practical problem solving
(that links and interdigitates with usual pulmonary rehabilitation) on the Hospital Anxiety and Depression
Scale in COPD. Contact with an investigator of this study and the other two protocols suggested data
would be available from each of these studies to determine the efficacy of the interventions on all of the
pre-specified outcome measures of this review. Additional details of the studies are provided in table 3.
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Discussion
The review identified only one quasi-randomised controlled trial assessing the efficacy of an intervention to
improve completion of pulmonary rehabilitation [21]. The intervention was the allocation of a tablet
computer (equipped with training diary, exercise videos and training results) to patients undergoing
outpatient pulmonary rehabilitation. Synthesis of the available data from this trial suggested that the
intervention had a small (but not statistically significant) effect in which, compared with usual care, use of
the tablet computer increased the likelihood for completion of pulmonary rehabilitation by 11%. This trial
must be interpreted in relation to the quality of the evidence. As a secondary effect parameter, the study
was underpowered to detect a significant difference between groups in completion rates. Further data,
provided by the study authors, also indicated a greater rate of session attendance throughout pulmonary
rehabilitation with use of the tablet computer. It is important to note that the major limitations in design of
the study (lack of concealed allocation, blinding) may confer a biased assessment of the intervention effect.
Strengths and limitations of the study
This review adhered to the pre-specified protocol using appropriate methods to select, evaluate and
synthesise all the relevant evidence. A comprehensive search for published and unpublished studies, which
included multiple electronic databases, scanning of bibliographies and contact with authors, yielded only
one published study. A strength of this review is that it presents the first attempt to collate and synthesise
the effects of interventions for improving patient uptake and completion of pulmonary rehabilitation. We
had strict definitions on outcome measures for the purpose of this review and did not consider other
outcomes, such as amount or frequency of unsupervised exercise/physical activity during or after
pulmonary rehabilitation. Some of the excluded studies did include interventions targeted at these
outcomes, but our primary interest was in those studies aiming to address the commonly reported poor
patient uptake and completion of pulmonary rehabilitation in COPD.
The lack of identification, and hence inclusion, of unpublished evidence is often considered a limitation in
systematic reviews. Effects estimated from published studies may be inflated due to bias towards the
nonpublication of studies with nonsignificant effects. However, the identification of only one published
study [21] with nonsignificant findings mitigates concerns about publication bias. Rather, this review
reveals major limitations in the available randomised controlled evidence in the area.
Comparison with other studies
There is currently no systematic review that has selected and critically appraised all of the randomised trial
evidence on interventions to improve uptake and completion of pulmonary rehabilitation. We are aware of
reviews evaluating the effect of interventions to improve patient uptake and adherence of rehabilitation in
cardiac populations [27]. Previous joint ATS/ERS statements and the BTS pulmonary rehabilitation
guidelines [5, 28] identified one study that improved patient completion of pulmonary rehabilitation via a
group-based session incorporating cognitive behavioural techniques [29]. This, however, was a
nonrandomised study with historical controls and the evidence was graded to have a high risk of
TABLE 2 Risk of bias of the included study [21]
Authors’ judgement Support for judgement
Random sequence generation Inadequate Allocated by alternation
Allocation concealment Inadequate No concealment
Blind outcome assessment Inadequate No blinding
Incomplete outcome data Adequate All participants who commenced the study are
accounted for
Selective reporting (reporting bias) Adequate Data for all primary and secondary measures
(detailed in the methods) has been reported
Other bias Inadequate Percentage predicted forced expiratory volume in 1 s
was lower in the intervention group and fewer
patients started pulmonary rehabilitation in the
winter than in the control group. These covariates
were reported as not being associated with outcomes
but data was not provided. Pulmonary rehabilitation
did not deliver similar improvements in routine
clinical outcome measures between groups
Overall risk of bias High More than one criterion deemed inadequate
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TABLE 3 Characteristics of ongoing studies
Study name or title Chief investigator Study period
(start and end
dates)
(country)
Study design Participants Intervention Comparison Outcomes
Pulmonary Rehabilitation
and ACTIvity after COPD
Exacerbations: the
PRACTICE trial: a
randomised trial [24]
R. Hughes January 2015 to
December 2016
(UK)
Parallel group,
randomised pilot
2×2 trial
76 participants with
clinically identified
exacerbation of
diagnosed COPD
1) In-hospital exercise
training followed by
in-home post-discharge
early rehabilitation;
2) standard in-hospital
care followed by in-home
post-discharge early
rehabilitation
1) In-hospital exercise
training followed by
standard discharge care;
2) standard in-hospital
care followed by
standard discharge
Subsequent uptake,
adherence and
completion of
group-based community
pulmonary rehabilitation
Video to Increase
RehabiliTation Uptake
following hospitalised
Exacerbations of COPD
(VIRTUE): a randomised
controlled trial [25]
W. Man January 2015 to
January 2017
(UK)
Parallel group,
randomised trial
200 adults aged >40 years
diagnosed with COPD,
admitted to hospital with
acute exacerbation of
COPD and fit enough to
take part in pulmonary
rehabilitation
Participants will be asked
to watch a 5-min
patient-designed video
promoting early
pulmonary rehabilitation
plus usual care
Usual care: provided with
standard verbal
information and an A5
patient information
leaflet about early
pulmonary rehabilitation
Uptake, adherence and
completion of
post-exacerbation
pulmonary rehabilitation
A tailored, psychological
intervention for mild to
moderate anxiety or
depression in people
with COPD: Tailored
intervention for ANxiety
and DEpression
Management in COPD
(TANDEM) [26]
S. Taylor April 2016 to
January 2021
(UK)
Three-phase study
(phase I:
preparation;
phase II: pilot
randomised
controlled trial;
phase III: a fully
powered
individually
randomised
controlled trial)
Adults with
moderate–severe COPD
with mild–moderate
comorbid anxiety or
depression and eligible
for attendance at their
local pulmonary
rehabilitation; phase II:
45 participants; phase
III: 430 participants
Tailored, one-to-one
psychological
intervention combined
with practical
problem-solving
components based on:
Self-management
Programme of Activity
Coping and Education
(SPACE) and The Lung
Manual, a nurse-led
intervention based on
cognitive behavioural
principles and
self-management, and
developed to address
mood disorders of
anxiety in COPD; this
psychological
intervention links into,
and interdigitates with,
usual pulmonary
rehabilitation, but is
independent of it
Usual care: standard
pulmonary rehabilitation
without interdigitating
psychological
intervention
Uptake and completion of
pulmonary rehabilitation
(to be informed by the
pre-pilot and pilot
studies)
COPD: chronic obstructive pulmonary disease.
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confounding, bias or chance and a significant risk that the relationship was not causal. Other reviews have
included quantitative studies and qualitative studies of attendance and adherence to pulmonary
rehabilitation but mainly focused on the identification of the barriers, not the evaluation of strategies to
address them [11, 16]. Systematic reviews of randomised trials assessing add-on/supplemental
interventions to pulmonary rehabilitation are also available, but the measures are limited to routine clinical
outcomes only (health-related quality of life and exercise capacity) [30, 31].
Implications for clinical practice and research
No recommendations for this crucial area of practice can be made given the current lack of evidence.
Application of an intervention with demonstrated efficacy will have important implications for clinical
practice. It is somewhat surprising to see a lack of simple practical interventions to support decision
making within the pulmonary rehabilitation service pathway. Poor patient uptake and completion in
conjunction with existing low referral rates of pulmonary rehabilitation imply a major failure in the
healthcare system [18]. The potential for these issues to undermine the effectiveness of pulmonary
rehabilitation, and put further burden on increasingly stringent financial resources, places emphasis on this
area as a research priority.
There is a strong rationale for enhancing patient uptake and completion of pulmonary rehabilitation but
further high-quality research is needed, particularly single-intervention strategies based on theoretical
frameworks or tailored to the key barriers that are relevant to the setting. We have identified at least three
ongoing randomised trials in the UK that will provide important new evidence, but only one of these
studies defines uptake or completion as a primary measure [25], and hence it is unlikely these studies
alone will lead to changes in practice nationally or internationally. We reiterate, with urgency, calls from
the 2013 BTS pulmonary rehabilitation guideline for robust, well-designed trials evaluating techniques
before and during pulmonary rehabilitation [28]. While we understand there will be interest in assessing
the long-term effects of interventions that improve patient compliance (e.g. clinical outcomes), current
focus should be placed on delivering short-term studies that evaluate more immediate impact on patients
(e.g. uptake of pulmonary rehabilitation).
Despite wide awareness of patient barriers to pulmonary rehabilitation, affirmed most recently by STEINER
and ROBERTS [10], our review highlights a concerning under-appreciation of intervention trials in this area.
Numerous qualitative studies and editorials have previously proposed potential interventions, but none of
these have been evaluated in a randomised trial context [32–39]. Conceivably, excluded studies in this
review consisted of interventions that when tested within an appropriate designed, adequately powered
trial may have a positive effect on uptake or completion of pulmonary rehabilitation. We also recognise
the calls for further studies on novel approaches to pulmonary rehabilitation (e.g. home-based, web-based,
telehealth support programmes) that were not considered for inclusion in this review, but may have the
potential to influence patient compliance through provision of a more acceptable setting.
It is reasonable to suggest that rehabilitation service providers may have previously attempted to overcome
challenges of patient uptake and completion by implementing changes without formal evaluation.
Recommendations have recently been made at both the national and international level for improvement
in access and quality of service provision of pulmonary rehabilitation [10, 19]. We feel this approach alone
will not maximise the opportunity to address the challenges of patient uptake and completion. The
completion of randomised trials will not only provide a robust platform to evaluate a range of
interventions (similar to which pulmonary rehabilitation itself is founded upon), but also provide clearer
pathways for the sharing of evidence within the wider respiratory communities. Interventions should be
developed with the timing and setting of pulmonary rehabilitation in mind, and whether they are best
targeted at all COPD patients or specific clinical phenotypes. This is pertinent for other chronic
respiratory conditions that are also referred to pulmonary rehabilitation.
Conclusions
With only one low-quality quasi-randomised trial included, there is insufficient evidence to guide clinical
practice with regard to interventions for improving patient uptake and completion of pulmonary
rehabilitation in COPD. The paucity of evidence in this area acts as a major limitation for any healthcare
services planning to address continuing challenges around patient uptake/completion of pulmonary
rehabilitation. Despite increasing awareness of patient barriers to pulmonary rehabilitation, our review
highlights the existing under-appreciation of intervention trials in this area and is an urgent call for more
evidence to guide the pulmonary rehabilitation service pathway. This knowledge gap should be viewed as
an area of research priority due to its likely impact in undermining wider implementation of pulmonary
rehabilitation and restricting patient access to a treatment considered the cornerstone of COPD. Future
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research should utilise high-quality study designs that aim to address the major modifiable barriers to
uptake and completion.
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